Clinical Trial: Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

U.S., Sept. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07195305) titled 'Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding' on Aug. 18.

Brief Summary: The present study aims to compare the efficacy (menstrual blood loss, pain, quality of life) and the safety (complications, recovery) of each conservative intervention (RFA, UAE) versus hysterectomy for the treatment of adenomyosis-related abnormal uterine bleeding, up to 2 years

Study Start Date: Nov., 2025

Study Type: INTERVENTIONAL

Condition: Abnormal Uterine Bleeding Due to Adenomyosis (Disorder)

Intervention: PROCEDURE: Radiofrequency endometrial ablation

Radiofreq...